@FierceBiotech: EuroBiotech: Britain fearful of Pfizer future, UCB on the hunt for antibody partners, Novartis snubs Transgene. Report | Follow @FierceBiotech
@JohnCFierce: Vintafolide is toast, fails PhIII. Release | Follow @JohnCFierce
@DamianFierce: $AGN says it's "golf-course deprived" but stays mum on rumored bouncey castle, ski ball machine and raw juice bar. More from the WSJ | Follow @DamianFierce
@EmilyMFierce: Looking to sales growth, Merck rolls out vaccine adherence plan. More from FierceVaccines | Follow @EmilyMFierce
> Novartis ($NVS) has backed out of a deal to buy Israeli biotech Gamida Cell for $600 million, according to local reports. Article
> Scynexis ($SCYX) pulled off a $62 million IPO after slashing its price. Item
> Aldeyra Therapeutics ($ALDX) raised $12 million in an IPO, pricing below its range at $8 a share. Story
@FierceMedDev: Veracyte is advancing into Brazil with its thyroid cancer Dx through an interesting new partnership. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: Updated with statement from company: Intuitive gets out from under FDA warning letter. Report | Follow @VarunSaxena2
@EmilyWFierce: More bad news for Endo: Company posted net losses of $436.9M and a drop in pharma sales in Q1. FiercePharma story | Follow @EmilyWFierce
@MichaelGFierce: ICYMI from FierceDrugDelivery: Oramed's oral insulin PhIIa details show a compromised study, and shares continue to fall. Article | Follow @MichaelGFierce
> CardioDx revives IPO plans with infusion of fresh leadership. More
> Mainstay Medical raises $25M in European IPO. Story
> GI Dynamics bags $32M in private placement. Item
Pharma News
@FiercePharma: Top-read special report: The top 10 pharma companies by 2013 revenue. Feature | Follow @FiercePharma
@TracyStaton: ICYMI this week: Allergan to propose to Shire again, but does Irish beauty want to get engaged? Story | Follow @TracyStaton
@EricPFierce: Taro expanding a plant in Canada. Provincial government will kick in about $10M of the $247M investment. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: Takeda wins $70M from Japan to bump up H5N1 vaccine production. FierceVaccines story | Follow @CarlyHFierce
> Pfizer's approach may turn hostile after AZ rejects second offer. Story
> Sun is closing Caraco plant in Detroit and whacking nearly 180 jobs. Article
> Reports: Bayer closing in on deal for Merck OTC unit with Reckitt out of the way. More